Longboard Pharmaceuticals Inc (LBPH)
18.80
-0.14
(-0.74%)
USD |
NASDAQ |
May 24, 16:00
18.78
-0.02
(-0.11%)
After-Hours: 20:00
Longboard Pharmaceuticals Total Assets (Quarterly): 327.66M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 327.66M |
| December 31, 2023 | 50.70M |
| September 30, 2023 | 58.86M |
| June 30, 2023 | 66.22M |
| March 31, 2023 | 79.68M |
| December 31, 2022 | 70.62M |
| September 30, 2022 | 80.66M |
| Date | Value |
|---|---|
| June 30, 2022 | 90.51M |
| March 31, 2022 | 100.64M |
| December 31, 2021 | 108.95M |
| September 30, 2021 | 115.95M |
| June 30, 2021 | 120.72M |
| March 31, 2021 | 123.63M |
| December 31, 2020 | 56.24M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
50.70M
Minimum
Dec 2023
327.66M
Maximum
Mar 2024
103.65M
Average
85.59M
Median
Total Assets (Quarterly) Benchmarks
| SIGA Technologies Inc | 243.15M |
| Mersana Therapeutics Inc | 198.37M |
| Pulmonx Corp | 164.58M |
| Maravai LifeSciences Holdings Inc | 1.445B |
| Caribou Biosciences Inc | 406.82M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.96M |
| Shareholders Equity (Quarterly) | 313.71M |